Pyruvate kinase isozyme M2 activators identified at the University of Michigan Feb. 17, 2022 No Comments
Skye reports data on SBI-100 ophthalmic nanoemulsion in preclinical glaucoma model Feb. 2, 2022 No Comments
Targeting secretogranin III induces antiangiogenic effect during choroidal neovascularization Jan. 31, 2022 No Comments
Seed funding at Ray Therapeutics supports development of RAY-001 for retinitis pigmentosa Jan. 5, 2022 No Comments
GAT-564, a novel CB1R allosteric modulator with efficacy in murine model of glaucoma Dec. 3, 2021 No Comments
Pridopidine has neuroprotective effects mediated by S1R in retinal ganglion cells of glaucoma models Nov. 24, 2021 No Comments